<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <title></title>
    <style type="text/css">

 p.MsoNormal
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	}
p.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	}
    </style>
</head>
<body>

    <p class="MsoNormal">
        <b style="mso-bidi-font-weight:normal">
        <span style="font-size:14.0pt;mso-bidi-font-size:11.0pt;line-height:115%">List 
        of amendments to the Physician MOU<o:p></o:p></span></b></p>
    <p class="MsoNormal">
        <span style="font-size:14.0pt;mso-bidi-font-size:11.0pt;
line-height:115%">September 2011<o:p></o:p></span></p>
    <p align="left" class="MsoBodyText2" style="margin-bottom:0in;margin-bottom:.0001pt;
text-align:left">
        <b style="mso-bidi-font-weight:normal"><span lang="EN-GB" 
            style="font-size:11.0pt">As partners in the administration of GIPAP TMF:<o:p></o:p></span></b></p>
    <p align="left" class="MsoBodyText2" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:39.1pt;margin-bottom:.0001pt;text-align:left;
text-indent:-.25in;mso-list:l0 level1 lfo1;tab-stops:list 39.1pt">
        <![if !supportLists]>
        <span lang="EN-GB" style="font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span 
            style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span></span></span><![endif]><span lang="EN-GB" style="font-size:11.0pt">
        Provides information concerning adverse events to Novartis for reporting to 
        Health Authorities as required<o:p></o:p></span></p>
    <p class="MsoNormal">
        <span lang="EN-GB" style="mso-ansi-language:EN-GB"><o:p>&nbsp;</o:p></span></p>
    <p class="MsoNormal">
        <b style="mso-bidi-font-weight:normal">
        <span style="font-size:14.0pt;mso-bidi-font-size:11.0pt;line-height:115%;mso-ascii-font-family:
Calibri;mso-fareast-font-family:Calibri;mso-hansi-font-family:Calibri;
mso-bidi-font-family:&quot;Times New Roman&quot;">The Max Foundation agrees to:<o:p></o:p></span></b></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:normal;mso-list:l1 level1 lfo2;tab-stops:list .5in">
        <![if !supportLists]>
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:Calibri">
        <span style="mso-list:Ignore">1.0<span 
            style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span></span></span><![endif]><u>
        <span style="mso-ascii-font-family:Calibri;
mso-fareast-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
&quot;Times New Roman&quot;">GIPAP ADMINISTRATION<o:p></o:p></span></u></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt">
        <span style="mso-ascii-font-family:
Calibri;mso-fareast-font-family:Calibri;mso-hansi-font-family:Calibri;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p>&nbsp;</o:p></span></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.0in;margin-bottom:.0001pt;text-indent:-.5in">
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;">1.5<span 
            style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span>Facilitate the reporting of Adverse Events (AE’s) as directed by 
        regulatory authorities in order to assure the highest standards of health and 
        safety for all GIPAP patients (see also section 6.0 Adverse Event Reporting);</span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt">
        <b style="mso-bidi-font-weight:normal"><u><o:p>
        <span style="text-decoration:none">&nbsp;</span></o:p></u></b></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt">
        <b style="mso-bidi-font-weight:normal"><u><o:p>
        <span style="text-decoration:none">&nbsp;</span></o:p></u></b></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt">
        <b style="mso-bidi-font-weight:normal"><u>
        <span style="font-size:14.0pt;
mso-bidi-font-size:11.0pt;line-height:115%;mso-ascii-font-family:Calibri;
mso-fareast-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
&quot;Times New Roman&quot;">The <st1:personname w:st="on">GIPAP</st1:PersonName> 
        Qualified Institution/Physician agrees to:<o:p></o:p></span></u></b></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.0in;margin-bottom:.0001pt;text-indent:-.5in">
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p>&nbsp;</o:p></span></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:7.1pt;margin-bottom:.0001pt;tab-stops:list 27.0pt">
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;">6.0<span 
            style="mso-tab-count:1">&nbsp;&nbsp; </span><u>ADVERSE EVENT REPORTING</u><o:p></o:p></span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;tab-stops:
list 27.0pt">
        <span 
            style="mso-ascii-font-family:Calibri;mso-fareast-font-family:
Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p>
        &nbsp;</o:p></span></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.0in;margin-bottom:.0001pt;text-indent:-64.9pt;tab-stops:27.0pt;
mso-layout-grid-align:none;text-autospace:none">
        <span style="mso-ascii-font-family:
Calibri;mso-fareast-font-family:Calibri;mso-hansi-font-family:Calibri;
mso-bidi-font-family:&quot;Times New Roman&quot;"><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span>6.1<span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span><span style="color:black">The Qualified Institution/Physician should 
        report adverse events as required by their national legislation;<o:p></o:p></span></span></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.0in;margin-bottom:.0001pt;text-indent:-64.9pt;tab-stops:list 27.0pt">
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;">
        <span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span><o:p></o:p></span>
    </p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.0in;margin-bottom:.0001pt;text-indent:-45.0pt;tab-stops:list 1.0in">
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;">6.2<span 
            style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span>Novartis has local Novartis Country Pharma Organizations (<st1:personname 
            w:st="on">CPO</st1:PersonName>’s) and <span style="color:black">the 
        information can</span> be reported to the Novartis <st1:personname w:st="on">CPO</st1:PersonName>’s 
        Drug Safety and Epidemiology Desk. The form shall be sent by fax to the number 
        provided by Novartis;<o:p></o:p></span></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.0in;margin-bottom:.0001pt;text-indent:-45.0pt;tab-stops:list 1.0in">
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;">.<o:p></o:p></span></p>
    <p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.0in;margin-bottom:.0001pt;text-indent:-45.0pt;tab-stops:list 1.0in">
        <span style="mso-ascii-font-family:Calibri;mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;mso-bidi-font-family:&quot;Times New Roman&quot;">6.3<span 
            style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </span>As noted in section 1.5, TMF will facilitate the reporting of Adverse 
        Events (AE’s) in order to assure the highest standards of health and safety for 
        all GIPAP patients.<span style="mso-spacerun:yes">&nbsp; </span>This means that 
        TMF will report to Novartis all AEs that they learn of through the participation 
        of a patient in the GIPAP program regardless of the seriousness or suspectedness 
        of the event.<span style="mso-spacerun:yes">&nbsp; </span>This reporting is 
        separate from the local reporting obligation that physicians must adhere to 
        based on their local reporting requirements.<span style="mso-spacerun:yes">&nbsp;
        </span>Novartis will direct all follow-up questions to the GIPAP physician 
        (including for reports received from patients and/or caregivers) and will submit 
        AE reports to Health Authorities as required.<o:p></o:p></span></p>
    <p class="MsoNormal">
        <o:p>&nbsp;</o:p></p>

</body>
</html>
